Published in Biostatistics on April 01, 2003
Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet (2013) 3.65
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med (2012) 2.40
Analyze multivariate phenotypes in genetic association studies by combining univariate association tests. Genet Epidemiol (2010) 2.19
Rare variant analysis for family-based design. PLoS One (2013) 1.72
Why Do We Test Multiple Traits in Genetic Association Studies? J Korean Stat Soc (2009) 1.62
Moving toward System Genetics through Multiple Trait Analysis in Genome-Wide Association Studies. Front Genet (2012) 1.32
Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. Am J Hum Genet (2014) 1.31
Methods for Analyzing Multivariate Phenotypes in Genetic Association Studies. J Probab Stat (2012) 1.20
A method for computing the overall statistical significance of a treatment effect among a group of genes. BMC Bioinformatics (2006) 1.18
Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. Biostatistics (2008) 1.02
A partially linear tree-based regression model for multivariate outcomes. Biometrics (2009) 0.99
Testing genetic association by regressing genotype over multiple phenotypes. PLoS One (2014) 0.87
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir. AIDS Res Hum Retroviruses (2010) 0.86
A methodology for multivariate phenotype-based genome-wide association studies to mine pleiotropic genes. BMC Syst Biol (2011) 0.85
Two-sample tests of area-under-the-curve in the presence of missing data. Int J Biostat (2008) 0.83
Omnibus risk assessment via accelerated failure time kernel machine modeling. Biometrics (2013) 0.79
A versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves. Stat Med (2015) 0.79
Power analysis of principal components regression in genetic association studies. J Zhejiang Univ Sci B (2009) 0.77
Using a Bayesian latent variable approach to detect pleiotropy in the Genetic Analysis Workshop 18 data. BMC Proc (2014) 0.77
Rare variant association test with multiple phenotypes. Genet Epidemiol (2016) 0.75
Statistical tests for detecting associations with groups of genetic variants: generalization, evaluation, and implementation. Eur J Hum Genet (2012) 0.75
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases. Front Genet (2016) 0.75
Application of computational methods in genetic study of inflammatory bowel disease. World J Gastroenterol (2016) 0.75
A nonparametric regression method for multiple longitudinal phenotypes using multivariate adaptive splines. Front Math China (2013) 0.75
Detecting Heterogeneity in Population Structure Across the Genome in Admixed Populations. Genetics (2016) 0.75
The Central Role of KNG1 Gene as a Genetic Determinant of Coagulation Pathway-Related Traits: Exploring Metaphenotypes. PLoS One (2016) 0.75
Robust differential expression analysis by learning discriminant boundary in multi-dimensional space of statistical attributes. BMC Bioinformatics (2016) 0.75
A genetic stochastic process model for genome-wide joint analysis of biomarker dynamics and disease susceptibility with longitudinal data. Genet Epidemiol (2017) 0.75
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med (2011) 4.34
Genomewide nonadditive gene regulation in Arabidopsis allotetraploids. Genetics (2005) 3.78
Prediction of cumulative incidence function under the proportional hazards model. Biometrics (1998) 3.32
Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med (2006) 2.73
Stochastic and epigenetic changes of gene expression in Arabidopsis polyploids. Genetics (2004) 2.62
Model-checking techniques based on cumulative residuals. Biometrics (2002) 2.58
Randomization in clinical trials: conclusions and recommendations. Control Clin Trials (1988) 2.38
Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol (2009) 2.37
Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med (2006) 2.32
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics (1990) 2.19
Simultaneous inferences on the contrast of two hazard functions with censored observations. Biometrics (2002) 2.18
Development of an emergency department work score to predict ambulance diversion. Acad Emerg Med (2006) 2.18
Small RNAs serve as a genetic buffer against genomic shock in Arabidopsis interspecific hybrids and allopolyploids. Proc Natl Acad Sci U S A (2009) 2.08
A unified Haseman-Elston method for testing linkage with quantitative traits. Am J Hum Genet (2000) 2.08
Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation (2006) 2.02
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med (2008) 2.01
Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2007) 1.92
Comparative analysis of gene sets in the Gene Ontology space under the multiple hypothesis testing framework. Proc IEEE Comput Syst Bioinform Conf (2004) 1.85
Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol (2008) 1.82
Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med (2011) 1.73
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med (2012) 1.70
Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol (2007) 1.67
Analysis of randomized comparative clinical trial data for personalized treatment selections. Biostatistics (2010) 1.64
Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. Radiology (2011) 1.64
Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol (2014) 1.59
Roles of dynamic and reversible histone acetylation in plant development and polyploidy. Biochim Biophys Acta (2007) 1.58
Calibrating parametric subject-specific risk estimation. Biometrika (2010) 1.54
NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest (2016) 1.53
A Perturbation Method for Inference on Regularized Regression Estimates. J Am Stat Assoc (2012) 1.53
Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease. J Am Coll Cardiol (2011) 1.49
Nocturnal intermittent hypoxia is independently associated with pain in subjects suffering from sleep-disordered breathing. Anesthesiology (2013) 1.49
Nonadditive regulation of FRI and FLC loci mediates flowering-time variation in Arabidopsis allopolyploids. Genetics (2006) 1.49
Linear regression analysis based on Buckley-James estimating equation. Biometrics (1992) 1.46
Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population. Prostate (2013) 1.45
Estimators and tests in the analysis of multiple nonindependent 2 x 2 tables with partially missing observations. Biometrics (1988) 1.44
Linking gene expression data with patient survival times using partial least squares. Bioinformatics (2002) 1.42
Nonparametric estimation for the difference or ratio of median failure times. Biometrics (1993) 1.42
Acute type B aortic intramural hematoma: treatment strategy and the role of endovascular repair. J Endovasc Ther (2010) 1.38
Predicting cardiovascular risk: so what do we do now? Arch Intern Med (2006) 1.36
Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA (2013) 1.35
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant (2010) 1.34
Physical activity during daily life and functional decline in peripheral arterial disease. Circulation (2008) 1.34
EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY. J Am Stat Assoc (2013) 1.33
Sensitivity of 70-mer oligonucleotides and cDNAs for microarray analysis of gene expression in Arabidopsis and its related species. Plant Biotechnol J (2004) 1.32
Predicting the restricted mean event time with the subject's baseline covariates in survival analysis. Biostatistics (2013) 1.29
The development of an Arabidopsis model system for genome-wide analysis of polyploidy effects. Biol J Linn Soc Lond (2004) 1.22
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study. Clin Trials (2012) 1.22
AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol (2013) 1.22
Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol (2006) 1.20
Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc (2008) 1.20
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc (2005) 1.16
Lower extremity nerve function in patients with lower extremity ischemia. Arch Intern Med (2006) 1.14
Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol (2011) 1.14
Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women. Am J Cardiol (2008) 1.13
Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res (2013) 1.12
Obesity, weight change, and functional decline in peripheral arterial disease. J Vasc Surg (2006) 1.12
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation (2008) 1.12
Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease. Circulation (2009) 1.12
Strongly green-photoluminescent graphene quantum dots for bioimaging applications. Chem Commun (Camb) (2011) 1.11
Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol (2011) 1.10
Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol (2007) 1.09
Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population. Mol Carcinog (2012) 1.09
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). J Infect Dis (2001) 1.07
Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys. Am J Clin Nutr (2013) 1.06
Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology (2013) 1.05
Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics (2012) 1.05
Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol (2012) 1.04
Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. Circulation (2008) 1.04
Nanoscale anionic macromolecules for selective retention of low-density lipoproteins. Biomaterials (2005) 1.03
Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging (2013) 1.03
Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. Biostatistics (2008) 1.02
Diffuse high intensity PD-L1 staining in thymic epithelial tumors. J Thorac Oncol (2015) 1.02
Methods for genome-wide analysis of gene expression changes in polyploids. Methods Enzymol (2005) 1.01
Baseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial disease. J Am Geriatr Soc (2009) 1.00
Social cognitive constructs and the promotion of physical activity in patients with peripheral artery disease. J Cardiopulm Rehabil Prev (2008) 0.99
Risk factors for dental implant failure: a strategy for the analysis of clustered failure-time observations. J Dent Res (2002) 0.98
One- and two-sample nonparametric inference procedures in the presence of a mixture of independent and dependent censoring. Biostatistics (2005) 0.98
Evaluating subject-level incremental values of new markers for risk classification rule. Lifetime Data Anal (2013) 0.97
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea. PLoS One (2013) 0.96
Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer. Quant Imaging Med Surg (2012) 0.96
Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. J Gerontol A Biol Sci Med Sci (2006) 0.95
Arabidopsis thaliana histone deacetylase 1 (AtHD1) is localized in euchromatic regions and demonstrates histone deacetylase activity in vitro. Cell Res (2006) 0.95
Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race. J Vasc Surg (2005) 0.95
Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2008) 0.94
Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Invest Radiol (2012) 0.94
Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. Radiology (2013) 0.94
Endovascular stenting for treatment of Nutcracker syndrome: report of 61 cases with long-term followup. J Urol (2011) 0.93
Frailty approach for the analysis of clustered failure time observations in dental research. J Dent Res (2005) 0.93
Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol (2011) 0.93
Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease. J Vasc Surg (2007) 0.92
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials. Curr Med Res Opin (2011) 0.92
Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease. Am J Cardiol (2008) 0.92
The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease. J Vasc Surg (2012) 0.91
Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines. Genet Test Mol Biomarkers (2011) 0.91
Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging. Angiogenesis (2012) 0.91